UA82854U - Method for correction of cytokine content in blood serum of patients after craniocerebral trauma of moderate severity - Google Patents

Method for correction of cytokine content in blood serum of patients after craniocerebral trauma of moderate severity

Info

Publication number
UA82854U
UA82854U UAU201302383U UAU201302383U UA82854U UA 82854 U UA82854 U UA 82854U UA U201302383 U UAU201302383 U UA U201302383U UA U201302383 U UAU201302383 U UA U201302383U UA 82854 U UA82854 U UA 82854U
Authority
UA
Ukraine
Prior art keywords
patients
correction
blood serum
moderate severity
craniocerebral trauma
Prior art date
Application number
UAU201302383U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Анатолий Леонидович Победенный
Юрий Петрович Семенец
Владимир Михайлович Чепелев
Максим Павлович Сидоренко
Original Assignee
Анатолий Леонидович Победенный
Юрий Петрович Семенец
Владимир Михайлович Чепелев
Максим Павлович Сидоренко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Анатолий Леонидович Победенный, Юрий Петрович Семенец, Владимир Михайлович Чепелев, Максим Павлович Сидоренко filed Critical Анатолий Леонидович Победенный
Priority to UAU201302383U priority Critical patent/UA82854U/en
Publication of UA82854U publication Critical patent/UA82854U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for correction of cytokine content in blood serum of patients after craniocerebral trauma of moderate severity in the postoperative period consists in the use of neuroprotective and symptomatic agents. Additionally Immunofan is used in official admissible doses and regime to achieve more effectiveness of the treatment.
UAU201302383U 2013-02-25 2013-02-25 Method for correction of cytokine content in blood serum of patients after craniocerebral trauma of moderate severity UA82854U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201302383U UA82854U (en) 2013-02-25 2013-02-25 Method for correction of cytokine content in blood serum of patients after craniocerebral trauma of moderate severity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201302383U UA82854U (en) 2013-02-25 2013-02-25 Method for correction of cytokine content in blood serum of patients after craniocerebral trauma of moderate severity

Publications (1)

Publication Number Publication Date
UA82854U true UA82854U (en) 2013-08-12

Family

ID=52274948

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201302383U UA82854U (en) 2013-02-25 2013-02-25 Method for correction of cytokine content in blood serum of patients after craniocerebral trauma of moderate severity

Country Status (1)

Country Link
UA (1) UA82854U (en)

Similar Documents

Publication Publication Date Title
IN2015DN00544A (en)
GB2513167B (en) Tetrahydrocannabivarin for use in the treatment of nausea and vomiting
IL221693A (en) Erbb3 inhibitors for use in the treatment of triple negative and basal-like breast cancers
MX2015013184A (en) Sublingual and buccal film compositions.
GB201111485D0 (en) Drug composition and its use in therapy
MX2019008817A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof.
MX348184B (en) Methods and compositions for treating hiv-associated diarrhea.
MX2016004741A (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent.
MX2016008397A (en) Composition for use in the treatment of persistent cough.
MX2015010296A (en) Treatment of multiple sclerosis with laquinimod.
PH12015502679A1 (en) Methods of treatment and compositions with xanthine oxidase inhibitors
HK1224175A1 (en) Composition for use in reducing scab formation and promoting healing
IN2014MN02269A (en)
MX2016014913A (en) Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ.
MY171526A (en) Pharmaceutical formulation for reducing frequency of urination and method of use thereof
MX2016016039A (en) Pharmaceutical formulation for reducing frequency of urination and method of use thereof.
UA82854U (en) Method for correction of cytokine content in blood serum of patients after craniocerebral trauma of moderate severity
WO2012044963A3 (en) Perfluorocarbons for use in treating pruritus
MX2016001177A (en) Treatment of multiple sclerosis with combination of laquinimod and flupirtine.
PH12016502107A1 (en) Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
GEP20196947B (en) Bremelanotide therapy for female sexual dysfunction
UA88007U (en) Method for preventing postoperative wound complications of allohernioplasty of anterior abdominal wall
MX2016011801A (en) Low-dose estradiol cream.
MY174065A (en) Methods and compositions for treating hiv-associated diarrhea
UA89330U (en) Method for preventing inflammatory syndrome of immunity restoration in hiv-infected patients with cerebral toxoplasmosis